Levetiracetam Actavis

Страна: Нова Зеландія

мова: англійська

Джерело: Medsafe (Medicines Safety Authority)

Активний інгредієнт:

Levetiracetam 500mg;  

Доступна з:

Teva Pharma (New Zealand) Limited

ІПН (Міжнародна Ім'я):

Levetiracetam 500 mg

Дозування:

500 mg

Фармацевтична форма:

Film coated tablet

Склад:

Active: Levetiracetam 500mg   Excipient: Colloidal silicon dioxide Crospovidone Magnesium stearate Opadry yellow 85F32371 Povidone

Тип рецепту:

Prescription

Виробник:

Neuland Laboratories Limited

Терапевтичні свідчення:

Use in epileptic patients aged 4 years and older, initially as add on therapy, in the treatment of partial onset seizures with or without secondary generalisation. Monotherapy in the treatment of partial onset seizures, with or without secondary generalisation, in patients from 16 years of age with newly diagnosed epilepsy. Add on therapy in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with Juvenile Myoclonic Epilepsy (JME). Add on therapy in the treatment of primary generalized tonic-clonic seizures in adults and children from 4 years of age with idiopathic generalized epilepsy (IGE).

Огляд продуктів:

Package - Contents - Shelf Life: Blister pack, PVC/Al - 60 tablets - 36 months from date of manufacture stored at or below 25°C - Bottle, plastic, HDPE with LDPE screw cap and tamper evident - 100 tablets - 36 months from date of manufacture stored at or below 25°C

Дата Авторизація:

2015-01-22